REVIEWS
IMAJ | volume 27
Journal 9, September 2025
pages: 596-601
The Role of Obesity in Autoimmune Disease Development
1 Rheumatic Disease Unit, Sanz Medical Center–Laniado Hospital, Netanya, Israel
2 Rheumatology Unit, Ariel University, Ariel, Israel
3 Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
4 Department of Pediatrics, Tzafon Medical Center, Lower Galilee, Israel
Summary
Obesity is a growing global health concern, with its prevalence contributing to the rise of multiple chronic conditions, including autoimmune diseases. In this review I explore the intricate relationship between obesity and autoimmunity, focusing on how excess adiposity can affect immune responses and promote the development of autoimmune disorders. Obesity alters adipose tissue architecture, promoting chronic low-grade inflammation and triggering the release of pro-inflammatory cytokines, which contribute to immune system dysregulation. Adipose tissue is no longer seen as merely an energy store but as an active endocrine organ that interacts with the immune system. The review delves into mechanisms such as the role of adipokines, altered T cell function, and the recruitment of immune cells to inflamed adipose tissue, which together exacerbate autoimmune risk in obese individuals. Genetic and environmental factors also play a critical role in these processes, as polymorphisms and high-fat diets have been shown to influence both obesity and autoimmune susceptibility. Last, the review explores potential therapeutic strategies, such as lifestyle interventions and targeting obesity-driven inflammatory pathways, which could mitigate autoimmunity. Understanding the connection between obesity and autoimmunity offers insights into more effective interventions for patients suffering from these intertwined conditions.